Marks Gilbert Lynn
AN2 Therapeutics, Inc. · Director
Marks Gilbert Lynn is listed in filings as Director at AN2 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 10, 2026, including 15 public disclosures. Recent filings connect the profile to AN2 Therapeutics, Inc. (ANTX). The current snapshot covers public activity from Jun 21, 2024 to Apr 10, 2026. Reported amounts are shown as $179.1K to $92.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||